Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00126919 · ClinicalTrials.gov registry record · Phase 4

Reduction of Topical Anesthetic Time for Subcutaneous Port Access Using Ultrasound

A Phase 4 study, sponsored by Connecticut Children's Medical Center.

Completed
Registry status
Phase 4
Development phase
40
Enrollment target

NCT00126919: Completed Phase 4 study, sponsored by Connecticut Children's Medical Center.

NCT00126919 is a Phase 4 study that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 40 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00126919, a Phase 4 study, has completed, sponsored by Connecticut Children's Medical Center.

COMPLETED
Registry status
Phase 4
Development phase
40 participants
Enrollment target

Study Summary

Children ages 3-17 who are undergoing port access receive both standard care, topical medicine for numbing (LMX4), and the study intervention which utilizes ultrasound to speed the onset of LMX4 from 30 minutes to 5 minutes. The procedures will be performed on 2 separate visits to the clinic. The child's pain with the access procedure is evaluated.

Interventions

  • DEVICE SonoPrep

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2004-10
Est. Completion 2006-10
Phase Phase 4

What the finished NCT00126919 record still lists

NCT00126919 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which SonoPrep is the first listed.

NCT00126919 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00126919 about?

NCT00126919 is a clinical study titled "Reduction of Topical Anesthetic Time for Subcutaneous Port Access Using Ultrasound". Children ages 3-17 who are undergoing port access receive both standard care, topical medicine for numbing (LMX4), and the study intervention which utilizes ultrasound to speed the onset of LMX4 from 30 minutes to 5 minutes. The procedures will be performed on 2 separate visits to the clinic. The ch...

What is the current status of trial NCT00126919?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2004-10. Estimated completion is 2006-10.

What interventions are being tested in trial NCT00126919?

The interventions under investigation include: SonoPrep (DEVICE).

Who is sponsoring clinical trial NCT00126919?

This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00126919's enrollment target sits among peer trials

40 1397th of 2000 higher than 533 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00126919, the US trial registry maintained by the National Library of Medicine. NCT00126919 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.